Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 5/20 | 0.43 |
| ▸ | BBOX1 | O75936 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Levulinic Acid SCHEMBL9767579 | 0.94 | — | — | |
| Levulinic Acid SCHEMBL21815796 | 0.94 | ALDH1A1 (0.62) | ALDH1A1FFAR3HDAC3HDAC1HDAC2 | |
| Levulinic Acid SCHEMBL21815652 | 0.94 | ALDH1A1 (0.62) | ALDH1A1FFAR3HDAC3HDAC1HDAC2 | |
| Levulinic Acid SCHEMBL10791493 | 0.94 | ALDH1A1 (0.62) | ALDH1A1FFAR3HDAC3HDAC1HDAC2 | |
| Levulinic Acid SCHEMBL2074646 | 0.94 | ALDH1A1 (0.62) | ALDH1A1FFAR3HDAC3HDAC1HDAC2 | |
| Levulinic Acid SCHEMBL25222492 | 0.94 | ALDH1A1 (0.62) | ALDH1A1FFAR3HDAC3HDAC1HDAC2 | |
| Levulinic Acid SCHEMBL21815632 | 0.94 | ALDH1A1 (0.62) | ALDH1A1FFAR3HDAC3HDAC1HDAC2 | |
| Levulinic Acid SCHEMBL21815731 | 0.94 | ALDH1A1 (0.62) | ALDH1A1FFAR3HDAC3HDAC1HDAC2 | |
| Levulinic Acid SCHEMBL11315082 | 0.94 | — | — | |
| Levulinic Acid SCHEMBL439419 | 0.94 | ALDH1A1 (0.62) | ALDH1A1FFAR3HDAC3HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2695870-B1 | Active pyrotechnic materials containing a combustion accelerating agent | DIEHL DEFENCE GMBH & CO KG (DE) | 2021-09-29 | — | — | EP | claimed |
| EP-2695871-B1 | High performance material for a pyrotechnic decoy flare with a fluorinated carbon compound | DIEHL DEFENCE GMBH & CO KG (DE) | 2021-03-03 | — | — | EP | claimed |
| US-9139487-B2 | Active composition for a decoy which radiates spectrally on combustion of the active composition, containing an additive | DIEHL BGT DEFENCE GMBH & CO. KG (DE) | 2015-09-22 | — | — | US | claimed |
| US-9133071-B2 | Active composition for a decoy which radiates spectrally on combustion of the active composition | DIEHL BGT DEFENCE GMBH & CO. KG (DE) | 2015-09-15 | — | — | US | claimed |
| US-20150047760-A1 | ACTIVE COMPOSITION FOR A DECOY WHICH RADIATES SPECTRALLY ON COMBUSTION OF THE ACTIVE COMPOSITION, CONTAINING AN ADDITIVE | DIEHL BGT DEFENCE GMBH & CO. KG (DE) | 2015-02-19 | — | — | US | claimed |
| US-20140060711-A1 | ACTIVE COMPOSITION FOR A DECOY WHICH RADIATES SPECTRALLY ON COMBUSTION OF THE ACTIVE COMPOSITION | DIEHL BGT DEFENCE GMBH & CO. KG (DE) | 2014-03-06 | — | — | US | claimed |
| US-12594345-B2 | Degradable hyaluronic acid hydrogels | ASCENDIS PHARMA A/S (DK) | 2026-04-07 | — | — | US | disclosed |
| EP-4610288-A1 | POLYMER PARTICLES WITH LIQUID ACTIVE MATERIALS IN CORE | Lalgudi, Ramanathan S. (US) | 2025-09-03 | — | — | EP | disclosed |
| EP-4448665-A1 | BIO-BASED POLYOLS, ESTERS, AND SURFACTANTS | Lalgudi, Ramanathan S. (US) | 2024-10-23 | — | — | EP | disclosed |
| US-20240254272-A1 | BIO-BASED POLYOLS, ESTERS, AND SURFACTANTS | LALGUDI RAMANATHAN S (US) | 2024-08-01 | — | — | US | disclosed |
| US-11932721-B2 | Bio-based polyols, esters, and surfactants | Lalgudi, Ramanathan S. (US) | 2024-03-19 | — | — | US | disclosed |
| WO-2023114250-A1 | BIO-BASED POLYOLS, ESTERS, AND SURFACTANTS | LALGUDI RAMANATHAN S (US) | 2023-06-22 | — | — | WO | disclosed |
| US-20230183412-A1 | BIO-BASED POLYOLS, ESTERS, AND SURFACTANTS | LALGUDI RAMANATHAN S (US) | 2023-06-15 | — | — | US | disclosed |
| US-20050054741-A1 | Mixtures containing 1,1,1,3,3-pentafluorobutane and 1,1,1,2,3,3,3-heptafluoropropane | SOLVAY FLUOR UND DERIVATE GMBH (DE) | 2005-03-10 | — | — | US | disclosed |
| US-20040149955-A1 | Non-combustible polyesterpolyol and/or polyetherpolyol preblend for producing foamed products | SOLVAY FLUOR UND DERIVATE GMBH (DE) | 2004-08-05 | — | — | US | disclosed |
| US-6730798-B2 | SIMULTANEOUS HALOGENATION AND HYDROXYLATION UNDER LACTONIZATION, AZIDATION, THEN AMINATION TO FORM 2(S),4(S),5(S),7(S)-2,7-DIALKYL-4-HYDROXY-5-AMINO-8-ARYL-OCTANOYL AMIDES | SPEEDEL PHARMA AG (CH) | 2004-05-04 | — | — | US | disclosed |
| US-20030149303-A1 | Process for the preparation of substituted octanoyl amides | NODEN PHARMA DAC (IE) | 2003-08-07 | — | — | US | disclosed |
| EP-1296935-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED OCTANOYL AMIDES | Speedel Pharma AG (CH) | 2003-04-02 | — | — | EP | disclosed |
| WO-2002002508-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED OCTANOYL AMIDES | SPEEDEL PHARMA AG (CH) | 2002-01-10 | — | — | WO | disclosed |
| US-3970713-A | Process for the production of allyl alcohol | BAYER AKTIENGESELLSCHAFT (DT) | 1976-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149303-A1 | Process for the preparation of substituted octanoyl amides | HDHD5, CYP51A1, PGLS | ALDH1A1 448/4885FFAR3 1346/4885HDAC3 721/4885 |
| US-12594345-B2 | Degradable hyaluronic acid hydrogels | CD44, H1-0, MMP1 | ALDH1A1 210/4885FFAR3 3317/4885HDAC3 100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.